FDA Approved: HEMLIBRA — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Hemlibra (emicizumab) from Genentech, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Hemlibra (emicizumab)

Snippet

SUPPL AP for HEMLIBRA (EMICIZUMAB)